Not applicableUnknownNCT04288141
What this trial is testing
Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies
Who this might be right for
HER2-positive Breast Cancer
King's College London 40